Muyco, Xyrus Jake .
HRN: 25-76-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/04/2025
04/11/2025
IV
200mg
Q6
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes